T0901317

T0901317 is an agonist of LXR and FXR used in studies of Apoptosis and Hormone Signaling and related signaling programs. It is especially relevant when investigators need a named chemical input and interpretable readouts connected to caspase-associated cell-death signaling and survival decisions and ligand-dependent transcriptional programs and endocrine regulation in apoptosis, cancer, and endocrinology models.

By activating LXR and FXR, T0901317 can be used to examine caspase-associated cell-death signaling and survival decisions and ligand-dependent transcriptional programs and endocrine regulation. The nuclear receptor annotation adds relevance to reporter-gene, receptor-binding, and transcriptional assays, together with downstream-response mapping in the same experimental setting. In apoptosis, cancer, and endocrinology models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

• Target-focused assays involving LXR and FXR
• Pathway perturbation studies connected to Apoptosis and Hormone Signaling and related signaling programs
• Agonist-response and downstream signaling studies
• Reporter-gene, receptor-binding, and transcriptional assays

Overall, T0901317 is appropriate when a defined chemical perturbant is needed to connect LXR and FXR with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in apoptosis, cancer, and endocrinology models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.